www.akampion.de Gehe zur Webseite
akampion we create visibility
Eingehende Links: | 1 |
Sprache/Land: | EN |
Webseiten Geschwindigkeit: | 0.414 Sekunden |
Kein Besucheraufkommen zu dieser Domain gefunden.
Wichtigste Keywords
InDex Pharmaceuticals drug candidate Kappaproct Phase III license agreement integrated amplification Australian patent office Unyvero core technology Curetis rights Almirall European detection
Serverdaten
Serverstandort: Deutschland
Die IP-Adresse lautet 82.165.209.215.
DNS-Daten
Host | Klasse | Typ | Ziel |
---|---|---|---|
akampion.de | IN | A | 89.31.143.10 |
akampion.de | IN | SOA | server1-ns1.udagdns.net |
akampion.de | IN | NS | server1-ns2.udagdns.net |
akampion.de | IN | NS | server1-ns1.udagdns.net |
akampion.de | IN | NS | server1-ns3.udagdns.net |
akampion.de | IN | MX | mx00.udag.de |
akampion.de | IN | MX | mx01.udag.de |
Server-Ping
PING akampion.de (89.31.143.10) 56(84) bytes of data. 64 bytes from 89.31.143.10: icmp_req=1 ttl=55 time=3.62 ms 64 bytes from 89.31.143.10: icmp_req=2 ttl=55 time=3.21 ms 64 bytes from 89.31.143.10: icmp_req=3 ttl=55 time=3.19 ms 64 bytes from 89.31.143.10: icmp_req=4 ttl=55 time=3.18 ms --- akampion.de ping statistics --- 4 packets transmitted, 4 received, 0% packet loss, time 600ms rtt min/avg/max/mdev = 3.183/3.303/3.620/0.187 ms
Die Seite hat eine Ladezeit von 0.414 Sekunden.
Die Verbinungszeit zum Server beträgt 3.62ms.
Backlinks
Domain | Linktext | Verlinkter Pfad |
---|---|---|
www.akampioneer.de | akampion | / |
HTTP-Header
HTTP-Tag | Wert |
---|---|
http_version | HTTP/1.1 |
statuscode | 200 |
date | Fri, 04 Apr 2014 09:59:53 GMT |
server | Apache |
x-powered-by | PHP/5.2.17 |
x-pingback | http://akampioneer.com/xmlrpc.php |
set-cookie | PHPSESSID=b265d63735175178b89a8a4b7ae6cd20; path=/ |
transfer-encoding | chunked |
content-type | text/html; charset=UTF-8 |
Meta Tags
Meta-Tag | Wert |
---|---|
author | www.akampion.com |
publisher | www.akampion.com |
copyright | www.akampion.com |
keywords | Corporate Communications, Reputation Management, Consulting, Strategy, Investor Relations, Public Re... |
audience | Alle |
page-type | Corporate Communications, Service, Consulting |
revisit-after | 14 days |
robots | index,follow |
content-language | EN-US |
content-type | text/html; charset=utf-8 |
Interne Links
Anchor | URL |
---|---|
akampion home | http://www.akampion.com/index.php |
.about akampion | http://www.akampion.com/akampion.php |
.professional approach | http://www.akampion.com/approach.php |
.people | http://www.akampion.com/services.php |
.clients & case studies | http://www.akampion.com/clients.php |
.contact | http://www.akampion.com/contact.php |
imprint | http://www.akampion.com/imprint.php |
disclaimer | http://www.akampion.com/disclaimer.php |
Externe Links
Anchor | URL |
---|---|
.blog | http://www.akampioneer.com |
Company News: InDex Pharmaceuticals and Almirall enter into a license agreement for European rights of the phase III drug candidate Kappaproct® | http://akampioneer.com/company-news/company-news-index-pharmaceuticals-and-almirall-enter-... |
InDex Pharmaceuticals | http://www.indexpharmab.com/index.html |
Almirall | http://www.almirall.com/en/ |
Company News: Curetis Obtains Key Patent for Unyvero™ Technology | http://akampioneer.com/company-news/company-news-curetis-obtains-key-patent-for-unyvero%e2... |
Curetis AG, | http://www.curetis.com |
follow us on twitter | http://twitter.com/akampion |
Ähnliche Domains
Letzte Aktualisierung: 04.04.2014 11:57